Ovid Therapeutics Inc. - Common Stock (NQ:OVID)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | - |
| Bid (Size) | 1.470 (3,100) |
| Ask (Size) | 1.490 (1,900) |
| Prev. Close | 1.500 |
| Today's Range | 1.500 - 1.500 |
| 52wk Range | 0.2425 - 2.010 |
| Shares Outstanding | 70,417,345 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Ovid Therapeutics Stock Rallied 18% Pre-Market – Here’s Why ↗
October 03, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
October 03, 2025
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
August 13, 2025
Top movers in Wednesday's session ↗
August 13, 2025
Top movers in Wednesday's after hours session ↗
April 23, 2025
Frequently Asked Questions
Is Ovid Therapeutics Inc. - Common Stock publicly traded?
Yes, Ovid Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Ovid Therapeutics Inc. - Common Stock trade on?
Ovid Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Ovid Therapeutics Inc. - Common Stock?
The ticker symbol for Ovid Therapeutics Inc. - Common Stock is OVID on the Nasdaq Stock Market
What is the current price of Ovid Therapeutics Inc. - Common Stock?
The current price of Ovid Therapeutics Inc. - Common Stock is 1.500
When was Ovid Therapeutics Inc. - Common Stock last traded?
The last trade of Ovid Therapeutics Inc. - Common Stock was at 11/25/25 04:00 PM ET
What is the market capitalization of Ovid Therapeutics Inc. - Common Stock?
The market capitalization of Ovid Therapeutics Inc. - Common Stock is 105.63M
How many shares of Ovid Therapeutics Inc. - Common Stock are outstanding?
Ovid Therapeutics Inc. - Common Stock has 106M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.